Search Results

PECARN
Specialty

PECARN

PECARN is the first federally-funded multi-institutional network for research in pediatric emergency medicine in the United States.

Article

A Coach’s Guide to Sudden Cardiac Arrest

View frequently asked questions and resources for school and YSO coaches regarding Ohio's Lindsay’s Law.

Article

Research

We are motivated to improve the outcomes of children requiring rehabilitation services through research and innovation. 

Nationwide Children’s Hospital Names Ray Bignall, MD, Chief Diversity and Health Equity Officer
News

Nationwide Children’s Hospital Names Ray Bignall, MD, Chief Diversity and Health Equity Officer

Nationwide Children’s Hospital announced today that O. N. Ray Bignall II, MD, FAAP, FASN, has been named the hospital’s chief diversity and health equity officer.

Sialorrhea (Drooling)
Condition

Sialorrhea (Drooling)

Sialorrhea, also known as hypersalivation or drooling, means excessive saliva flow. Anterior sialorrhea is when patients have forward spillage of saliva from their mouths onto their faces and clothes. Posterior sialorrhea is when patients have spillage of saliva from their mouths down their airways.

Constipation
Condition

Constipation

Many children have constipation at one time or another. Constipation can be defined as more than three days between bowel movements; stools that are large, hard and painful to pass; or incomplete bowel movements and stool backs up in the bowel despite daily bowel movements.

Article

Low Maintenance Contraceptives

Low maintenance contraceptives, also called Long Acting Reversible Contraception (LARC,) are the most effective reversible methods of birth control available to reduce unplanned teen pregnancy.

Post-Surgery
Article

Post-Surgery

Learn what happens immediately after your child leaves the operating room and recovers in our Cardiothoracic Intensive Care Unit (CTICU).

Phase 1 Study Shows Encouraging Data for Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
News

Phase 1 Study Shows Encouraging Data for Gene Replacement Therapy for Spinal Muscular Atrophy Type 1

A one-time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published today in the New England Journal of Medicine. The study was conducted by Researchers from Nationwide Children’s Hospital in collaboration with AveXis, Inc. and The Ohio State University College of Medicine.

Article

Chaudhari Lab

The Chaudhari Lab is interested in developing, implementing and evaluating strategies to improve the integration of timely genetic diagnosis into clinical care, emphasizing that pediatric genomic medicine is a vital component of a learning health system.

Most Popular Pages
Specialty

Asthma Program

Specialty

Clinical Therapies

Condition

Headaches

Condition

Nasal Congestion